These may include nausea, diarrhoea, abdominal cramping, or indigestion
The main takeaway is simple: sitagliptin can support blood sugar control, but it is not a primary weight-loss therapy
Hellstrm PM, Hein J, Bytzer P, Bjrnssn E, Kristensen J, Schambye H (2009) Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
CagriSema leverages synergistic mechanisms: Semaglutide slows gastric emptying, suppresses glucagon, stimulates insulin, and reduces appetite, while Cagrilintide enhances satiety and further delays gastric emptying via brainstem pathways
Kelly has become the go-to expert for patients struggling with chronic pain, sports injuries, and joint conditions
European Journal of Endocrinology, 166 (5), 765-778